- Filed
- Sep 3, 2021 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2020 · Aug 27, 2020 | 598.98M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2020 | 774.46M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2020 | 557.81M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2019 | 52.76M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2019 | 49.21M sh |
| Operating Cash Flow | Q2 2020 · Jun 30, 2020 | −$458.65K |
| Operating Cash Flow | Q2 2020 · Jun 30, 2019 | −$453.22K |
| Cash And Equivalents | Q2 2020 · Jun 30, 2020 | $29.26K |
| Cash And Equivalents | Q2 2020 · Dec 31, 2019 | $67.61K |
| Stockholders Equity restated | Q2 2020 · Jun 30, 2020 | −$11.4M |
| Stockholders Equity | Q2 2020 · Mar 31, 2020 | −$19.89M |
| Stockholders Equity | Q2 2020 · Dec 31, 2019 | −$10.13M |
| Stockholders Equity | Q2 2020 · Jun 30, 2019 | −$1.53M |
| Stockholders Equity | Q2 2020 · Mar 31, 2019 | $1.69M |
| Stockholders Equity | Q2 2020 · Dec 31, 2018 | $1.71M |
| Current Liabilities restated | Q2 2020 · Jun 30, 2020 | $15.07M |
| Current Liabilities | Q2 2020 · Dec 31, 2019 | $14.29M |
| Total Liabilities restated | Q2 2020 · Jun 30, 2020 | $15.07M |
| Total Liabilities | Q2 2020 · Dec 31, 2019 | $14.29M |
| Current Assets | Q2 2020 · Jun 30, 2020 | $416.89K |
| Current Assets | Q2 2020 · Dec 31, 2019 | $224.74K |
| Total Assets | Q2 2020 · Jun 30, 2020 | $4.37M |
| Total Assets | Q2 2020 · Dec 31, 2019 | $4.37M |
| Eps Diluted | Q2 2020 · Jun 30, 2020 | $0.00 |
| Eps Diluted | Q2 2020 · Jun 30, 2020 | −$0.01 |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | −$0.07 |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | −$0.09 |
| Eps Basic | Q2 2020 · Jun 30, 2020 | $0.01 |
| Eps Basic | Q2 2020 · Jun 30, 2020 | −$0.01 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | −$0.07 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | −$0.09 |
| Sga Expense | Q2 2020 · Jun 30, 2020 | $592.04K |
| Sga Expense | Q2 2020 · Jun 30, 2020 | $1.14M |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $415.34K |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $1.08M |
| Rd Expense | Q2 2020 · Jun 30, 2020 | $5K |
| Rd Expense | Q2 2020 · Jun 30, 2020 | $5K |
| Rd Expense | Q2 2020 · Jun 30, 2019 | $3.79K |
| Rd Expense | Q2 2020 · Jun 30, 2019 | $3.79K |
| Net Income restated | Q2 2020 · Jun 30, 2020 | $7.02M |
| Net Income restated | Q2 2020 · Jun 30, 2020 | −$3.26M |
| Net Income | Q2 2020 · Mar 31, 2020 | −$10.28M |
| Net Income | Q2 2020 · Jun 30, 2019 | −$3.53M |
| Net Income | Q2 2020 · Jun 30, 2019 | −$4.45M |
| Net Income | Q2 2020 · Mar 31, 2019 | −$920.32K |
| Operating Income | Q2 2020 · Jun 30, 2020 | −$213.07K |
| Operating Income | Q2 2020 · Jun 30, 2020 | −$721.55K |
| Operating Income | Q2 2020 · Jun 30, 2019 | −$408.54K |
| Operating Income | Q2 2020 · Jun 30, 2019 | −$1.04M |
| Revenue | Q2 2020 · Jun 30, 2020 | $881.17K |
| Revenue | Q2 2020 · Jun 30, 2020 | $1.15M |
| Revenue | Q2 2020 · Jun 30, 2019 | $118.86K |
| Revenue | Q2 2020 · Jun 30, 2019 | $314.82K |
| Capex | Q2 2020 · Jun 30, 2019 | $2.52K |